Exact Mass: 417.174
Exact Mass Matches: 417.174
Found 128 metabolites which its exact mass value is equals to given mass value 417.174
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(-)-1-[(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy]methyl-2-ethoxy-2-methylpropyl acetate
C22H27NO7_3,5,7,9-Undecatetraenoic acid, 2-ethylidene-11-[4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hex-1-yl]-4,10-dimethyl-11-oxo-, methyl ester, (2Z,3E,5E,7E,9E)
Ala Cys Pro Gln
Ala Cys Gln Pro
Ala Pro Cys Gln
Ala Pro Gln Cys
Ala Gln Cys Pro
Ala Gln Pro Cys
Cys Ala Pro Gln
Cys Ala Gln Pro
Cys Pro Ala Gln
Cys Pro Gln Ala
Cys Gln Ala Pro
Cys Gln Pro Ala
Gly Met Asn Pro
Gly Met Pro Asn
Gly Asn Met Pro
Gly Asn Pro Met
Gly Pro Met Asn
Gly Pro Asn Met
Met Gly Asn Pro
Met Gly Pro Asn
Met Asn Gly Pro
Met Asn Pro Gly
Met Pro Gly Asn
Met Pro Asn Gly
Asn Gly Met Pro
Asn Gly Pro Met
Asn Met Gly Pro
Asn Met Pro Gly
Asn Pro Gly Met
Asn Pro Met Gly
Pro Ala Cys Gln
Pro Ala Gln Cys
Pro Cys Ala Gln
Pro Cys Gln Ala
Pro Gly Met Asn
Pro Gly Asn Met
Pro Met Gly Asn
Pro Met Asn Gly
Pro Asn Gly Met
Pro Asn Met Gly
Pro Gln Ala Cys
Pro Gln Cys Ala
Gln Ala Cys Pro
Gln Ala Pro Cys
Gln Cys Ala Pro
Gln Cys Pro Ala
Gln Pro Ala Cys
Gln Pro Cys Ala
1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium methyl sulphate
ZSTK474
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Benzenebutanamide,4-fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl
9-alpha-D-Glucopyranosyl-N-[(2-methoxyphenyl)methyl]-9H-purin-6-amine
5-(4-Methyl-benzoylamino)-biphenyl-3,4-dicarboxylic acid 3-dimethylamide-4-hydroxyamide
Closiramine aceturate
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
(2E,6R)-6-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}hept-2-enoic acid
N-[4-[3-[4-(5-chloro-2-methylphenyl)-1-piperazinyl]-2-hydroxypropoxy]phenyl]acetamide
(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine
(2R)-({4-[Amino(imino)methyl]phenyl}amino){5-ethoxy-2-fluoro-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl}aceticacid
N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide
(3Z)-3-[(2E,4E,6R)-1-hydroxy-4-methyl-6-[(2S,7R,8R)-1,2,7-trimethyl-5-oxo-3,9,10-trioxatricyclo[4.3.1.02,4]decan-8-yl]hepta-2,4-dienylidene]pyrrolidine-2,4-dione
(2E,3E,5E,7E,9E)-2-ethylidene-11-[(1R,4S,5R)-4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoic acid
N-[4-[[2-methoxy-5-(4-oxo-2,3-dihydro-1H-quinazolin-2-yl)phenyl]methoxy]phenyl]acetamide
2-amino-7-methyl-5-oxo-6-(2-phenylethyl)-4-(3-pyridinyl)-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester
methyl (2Z,3E,5E,7E,9E)-2-ethylidene-11-[4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
3-[6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-6-oxohexyl]-2-sulfanylidene-1H-quinazolin-4-one
2-(1-Benzimidazolyl)acetic acid [2-[1-(4-methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester
3-Furanyl-[4-[2-(3-methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
2-Furanyl-[4-[2-(4-methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
3-Furanyl-[4-[2-(4-methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
2-ethyl-4-[[(3-methyl-2-benzofuranyl)-oxomethyl]amino]-1H-1,5-benzodiazepine-3-carboxylic acid ethyl ester
2-amino-6-(3-imidazol-1-ylpropyl)-4-(2-methoxyphenyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile
1-(3-Chlorophenyl)-3-[[1-[(2,5-dimethoxyphenyl)methyl]-4-piperidinyl]methyl]urea
Methyl (2E,3E,5E,7E,9E)-2-ethylidene-11-[(1R,5R)-4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
1-(4-(5-(Furan-2-yl)-2-(3-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanone
1-[(2S,3S,6S)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2R,3S,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2R,3R,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2S,3S,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2R,3R,6S)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}-2,2-diphenylacetamide
Tyroserleutide (hydrochloride)
Tyroserleutide hydrochloride, isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2].